国药控股专业药房（东方）有限公司90%股权

{"sellerlist":{"utrgcemsseller":[{"hqcode":"9111*开通会员可解锁*8C","sellerid":"22105","createtime":"*开通会员可解锁* 11:16:18.000","id":"22105-161144","sellertype":"A11001","economynature":"A19002","sfqdpz":"0","sellername":"国药控股海南有限公司","projectid":"500171","recordtype":"A00001","monitorname":"A02001","sellerstockpercent":"90","pch":"161144","sharesunit":"1","selleraddress":"海南省海口市龙华区","managerscale":"A04002","sellpercent":"90","hqname":"中国医药集团有限公司","industrycode":"F51","decisionfiletype":"A07006","sellercode":"9*开通会员可解锁*36689Y","lastupdatetime":"*开通会员可解锁* 13:52:43.441","economytype":"A05003","legalcontactphone":"*开通会员可解锁*","zone":"460106","sellerrole":"07"}]},"holderlist":{"utrgcemsshareholder":[{"createtime":"*开通会员可解锁* 11:16:18.000","id":"23045-161144","holderno":"1","pch":"161144","lastupdatetime":"*开通会员可解锁* 13:52:43.452","holdername":"国药控股海南有限公司","projectid":"500171","holdingratio":"90","objectid":"500171","holderid":"23045","recordtype":"A00001"}, {"createtime":"*开通会员可解锁* 11:16:18.000","id":"23046-161144","holderno":"2","pch":"161144","lastupdatetime":"*开通会员可解锁* 13:52:43.452","holdername":"海南全泽复医疗科技有限公司","projectid":"500171","holdingratio":"10","objectid":"500171","holderid":"23046","recordtype":"A00001"}]},"utrgcemspreproject":{"projecttype":"PG3","bjhlpuburl":"https://otc.cbex.com/cgq/detail/500171.html","businessstatus":"A01001","expiredate":"*开通会员可解锁*","object":"国药控股专业药房（东方）有限公司90%股权","procontactemail":"tyzhao@cbex.com.cn","projectcode":"G32025BJ1000504-0","publishdate":"*开通会员可解锁*","createtime":"*开通会员可解锁* 11:16:18.000","id":"6665-161144","procontactmobile":"*开通会员可解锁*","projectid":"500171","recordtype":"A00001","istransferofctrl":"T","pch":"161144","procontact":"赵经理","sfwwxs":"0","isbind":"F","deptcontactmobile":"*开通会员可解锁*","duration":"20","lastupdatetime":"*开通会员可解锁* 13:52:43.425","deptcontact":"陈经理"},"utrgcemspreobject":{"zonecounty":"海南省东方市八所镇人民南路东五巷住宅楼铺面首层","registeredaddress":"海南省东方市八所镇人民南路东五巷住宅楼铺面首层","stmtprofit":"0.000715","stmtnetprofit":"0.000715","economynature":"A19002","stmtdebt":"86.96","paidfunding":"100.00万元(人民币)","recordtype":"A00001","auditequity":"-84.34","auditearning":"0.003628","pch":"161144","auditunit":"天健会计师事务所（特殊普通合伙）","industrycodezw":"零售业","stmtearning":"0","audityear":"2024","sellpercent":"90","stmtgrossprofit":"0.000715","auditdebt":"87.03","decisionfiletype":"A07006","zonecityzw":"省直辖县级行政单位","registeredcapital":"100.00万元(人民币)","objectid":"500171","auditgrossprofit":"0.49","auditprofit":"0.49","stmttype":"月报","stmtequity":"-84.34","objectname":"国药控股专业药房（东方）有限公司","id":"6665-161144","createtime":"*开通会员可解锁* 11:16:18.000","estabdate":"*开通会员可解锁*","zonecity":"469000","projectid":"500171","stmtasset":"2.63","auditasset":"2.69","auditnetprofit":"0.49","managerscale":"A04004","businessscope":"许可项目：药品零售；第三类医疗器械经营；特殊医学用途配方食品销售；婴幼儿配方乳粉销售；食品经营（销售散装食品）；保健食品销售；货物进出口；技术进出口；进出口代理（依法须经批准的项目，经相关部门批准后方可开展经营活动）一般项目：第一类医疗器械销售；第二类医疗器械销售；食品经营（仅销售预包装食品）；日用百货销售；化妆品零售；农副产品销售；体育用品及器材零售；办公设备耗材销售；信息咨询服务（不含许可类信息咨询服务）；化工产品销售（不含许可类化工产品）；市场营销策划；非居住房地产租赁；电子专用材料销售；电子元器件批发；电子元器件零售；塑料制品销售；橡胶制品销售；密封件销售；电池销售；互联网销售（除销售需要许可的商品）；食品互联网销售（仅销售预包装食品）；消毒剂销售（不含危险化学品）；供应链管理服务；健康咨询服务（不含诊疗服务）；远程健康管理服务；企业管理咨询；建筑材料销售；办公用品销售；文具用品零售；普通货物仓储服务（不含危险化学品等需许可审批的项目）；会议及展览服务；家用电器销售（除许可业务外，可自主依法经营法律法规非禁止或限制的项目）","zoneprovince":"460000","objectboss":"鲁小华","stmtdate":"*开通会员可解锁*","industrycode":"F52","objectcode":"91460000MA5TCPEJ0H","lastupdatetime":"*开通会员可解锁* 13:52:43.446","zoneprovincezw":"海南省","economytype":"A05003","zone":"469000"},"utrgcemsprepubinfo":{"importantinfo":"1、本次产权转让如导致国家出资企业及其子企业失去标的企业实际控制权的，交易完成后标的企业不得再继续使用国家出资企业及其子企业的字号、经营资质和特许经营权等无形资产，不得继续以国家出资企业子企业名义开展经营活动。\n2、本次产权转让行为尚待报请有权批准单位批准后进行正式信息披露，项目信息以正式信息披露内容为准。","pch":"161144","announcemethod":"A16002","createtime":"*开通会员可解锁* 11:16:18.000","buyerpostulate":"以正式信息披露内容为准。","id":"6665-161144","lastupdatetime":"*开通会员可解锁* 13:52:43.452","projectlinkurl":"https://otc.cbex.com/cgq/detail/500171.html","projectid":"500171","recordtype":"A00001","pubid":"500171"}}

转让标的基本情况

决策及批准情况

受让方资格条件

其他披露事项

一、转让方承诺

本转让方拟转让持有标的企业产权，并委托北京产权交易所公开预披露信息和组织交易活动。依照公开、公平、公正、诚信的原则作如下承诺： 点击查看承诺全文

二、转让标的基本情况

三、决策及批准情况

四、受让方资格条件

五、其他披露事项